Common ownership in the US pharmaceutical industry: A network analysis

Mostra el registre complet Registre parcial de l'ítem

  • dc.contributor.author Banal-Estañol, Albert
  • dc.contributor.author Newham, Melissa
  • dc.contributor.author Seldeslachts, Jo
  • dc.contributor.other Universitat Pompeu Fabra. Departament d'Economia i Empresa
  • dc.date.accessioned 2024-11-14T10:09:42Z
  • dc.date.available 2024-11-14T10:09:42Z
  • dc.date.issued 2020-10-22
  • dc.date.modified 2024-11-14T10:07:22Z
  • dc.description.abstract We investigate patterns in common ownership networks between firms that are active in the US pharmaceutical industry for the period 2004-2014. Our main findings are that "brand firms" -i.e. firms that have R&D capabilities and launch new drugs- exhibit relatively dense common ownership networks with each other that further increase significantly in density over time, whereas the network of "generic firms" -i.e. firms that primarily specialize in developing and launching generic drugs- is much sparser and stays that way over the span of our sample. Finally, when considering the common ownership links between brands firms, on the one hand, and generic firms, on the other, we find that brand firms have become more connected to generic firms over time. We discuss the potential antitrust implications of these findings.
  • dc.format.mimetype application/pdf*
  • dc.identifier https://econ-papers.upf.edu/ca/paper.php?id=1752
  • dc.identifier.citation
  • dc.identifier.uri http://hdl.handle.net/10230/68583
  • dc.language.iso eng
  • dc.relation.ispartofseries Economics and Business Working Papers Series; 1752
  • dc.rights L'accés als continguts d'aquest document queda condicionat a l'acceptació de les condicions d'ús establertes per la següent llicència Creative Commons
  • dc.rights.accessRights info:eu-repo/semantics/openAccess
  • dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/es/
  • dc.subject.keyword common ownership networks
  • dc.subject.keyword pharmaceutical companies
  • dc.subject.keyword competition
  • dc.subject.keyword innovation
  • dc.subject.keyword Business Economics and Industrial Organization
  • dc.title Common ownership in the US pharmaceutical industry: A network analysis
  • dc.title.alternative
  • dc.type info:eu-repo/semantics/workingPaper